Standard Chemical & Pharmaceutical Co., Ltd. (TPE:1720)
Taiwan · Delayed Price · Currency is TWD 60.10
+0.10 (0.17%)
Dec 23, 2025, 1:35 PM CST
TPE:1720 Market Cap
TPE:1720 has a market cap or net worth of 10.74 billion as of December 23, 2025. Its market cap has decreased by -6.09% in one year.
Market Cap
10.74B
Enterprise Value
12.68B
Revenue
6.91B
Ranking
n/a
PE Ratio
12.03
Stock Price
60.10
Market Cap Chart
Since March 4, 1996, TPE:1720's market cap has increased from 2.29B to 10.74B, an increase of 368.16%. That is a compound annual growth rate of 5.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 22, 2025 | 10.72B | -3.07% |
| Dec 31, 2024 | 11.06B | -6.07% |
| Dec 29, 2023 | 11.78B | 7.15% |
| Dec 30, 2022 | 10.99B | 42.69% |
| Dec 30, 2021 | 7.70B | 14.32% |
| Dec 31, 2020 | 6.74B | 11.87% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 248.14B |
| PharmaEssentia | 182.89B |
| Heron Neutron Medical | 85.13B |
| Lotus Pharmaceutical | 74.42B |
| Bora Pharmaceuticals Co., LTD. | 62.46B |
| Lin BioScience | 33.67B |
| Lumosa Therapeutics | 30.91B |
| Center Laboratories | 28.37B |